Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Jon C. Ogg | Apr 18, 2011 at 12:01 PM EDT

Merger Watch: Just How Much Can Tenet Fetch? (CYH, THC)

Community Health Systems, Inc. (NYSE: CYH) was one we flagged over the weekend for “the biggest analyst calls of the…

Jon C. Ogg | Apr 18, 2011 at 11:01 AM EDT

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

The drug sector has become rather boring and investors already know all about the ongoing patent expiration threats that loom…

Jon C. Ogg | Apr 18, 2011 at 9:17 AM EDT

BioWatch: Amarin Joins Ten-Bagger Chase (AMRN)

Amarin Inc. (NASDAQ: AMRN) just went off the charts, literally. The company reported very solid Phase III study results this…

Douglas A. McIntyre | Apr 12, 2011 at 8:35 PM EDT

Buying A $100,000 Kidney: A Story of Supply and Demand

The idea of compensating donors of vital organs, which strikes many as morally repugnant, is gaining acceptance among some parts…

Jon C. Ogg | Apr 11, 2011 at 2:01 PM EDT

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Biotech is becoming the ever-shrinking stock sector. It is almost weekly now that a new biotech acquisition is announced. Big Pharma in…

Jon C. Ogg | Apr 11, 2011 at 11:11 AM EDT

Dividend Watch: Making Income From Healthcare Facility REITs (OHI, MPW)

We have been featuring many REITs for their high dividends on our daily “Dividend Watch” pieces. One sector which has not…

Jon C. Ogg | Apr 6, 2011 at 10:08 AM EDT

BioWatch: Curis Gets Further on Cancer Map (CRIS)

Curis Inc. (NASDAQ: CRIS) is not exactly a household name, even when it comes to the land of biotech investors. …

Jon C. Ogg | Apr 5, 2011 at 11:30 AM EDT

BioWatch: Cubist Moves Beyond Patent Fears (CBST, TEVA)

Cubist Pharmaceuticals Inc. (NASDAQ: CBST) is going to be back in favor now that it has settled a key patent…

Jon C. Ogg | Apr 4, 2011 at 9:38 AM EDT

BioWatch: VIVUS & Orexigen Looking More FDA-Favorable (VVUS, OREX, ARNA)

VIVUS Inc. (NASDAQ: VVUS) was recently shown as one of our five biotechs with 50% upside and news this morning…

Jon C. Ogg | Apr 1, 2011 at 12:17 PM EDT

BioWatch: Dendreon Looks Even Brighter (DNDN)

Earlier this week, we highlighted Dendreon Corporation (NASDAQ: DNDN) as one of five biotechs with 50% implied upside. A new…

Jon C. Ogg | Mar 31, 2011 at 8:55 AM EDT

DrugWatch: K-V Tries a Do-Over Approach on Makena (KV-A)

When we first covered K-V Pharmaceutical Co. (NYSE: KV-A) for its Makena drug market exclusivity to prevent premature birth, we…

Jon C. Ogg | Mar 30, 2011 at 10:48 AM EDT

BioWatch: Biotechs With 50% Implied Upside (GENZ, CEPH, ALNY, DNDN, GERN, HALO, VVUS)

Biotech is about to become even less of a diversified sector due to mergers and acquisitions. Genzyme Corporation (NASDAQ: GENZ)…

Jon C. Ogg | Mar 29, 2011 at 1:01 PM EDT

IPO Watch: The Alternative Genzyme IPO (SNY, GENZ, GCVRZ, BBH, IBB, FBT)

The proposed buyout of Genzyme Corporation (NASDAQ: GENZ) by Sanofi-Aventis (NYSE: SNY) should close this week. We are about to…

Jon C. Ogg | Mar 29, 2011 at 9:25 AM EDT

BioWatch: CryoLife Acquisition, It Is Not Crying (CRY, CGCP)

CryoLife, Inc. (NYSE: CRY) is one we generally consider as devices rather than true biohealth, but it often falls under…

Jon C. Ogg | Mar 28, 2011 at 10:01 AM EDT

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval…

1 … 327 328 329 330 331 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Merger Watch: Just How Much Can Tenet Fetch? (CYH, THC)

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

BioWatch: Amarin Joins Ten-Bagger Chase (AMRN)

Buying A $100,000 Kidney: A Story of Supply and Demand

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Dividend Watch: Making Income From Healthcare Facility REITs (OHI, MPW)

BioWatch: Curis Gets Further on Cancer Map (CRIS)

BioWatch: Cubist Moves Beyond Patent Fears (CBST, TEVA)

BioWatch: VIVUS & Orexigen Looking More FDA-Favorable (VVUS, OREX, ARNA)

BioWatch: Dendreon Looks Even Brighter (DNDN)

DrugWatch: K-V Tries a Do-Over Approach on Makena (KV-A)

BioWatch: Biotechs With 50% Implied Upside (GENZ, CEPH, ALNY, DNDN, GERN, HALO, VVUS)

IPO Watch: The Alternative Genzyme IPO (SNY, GENZ, GCVRZ, BBH, IBB, FBT)

BioWatch: CryoLife Acquisition, It Is Not Crying (CRY, CGCP)

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

Health and Healthcare Articles

All Health and Healthcare Articles

Merger Watch: Just How Much Can Tenet Fetch? (CYH, THC)

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

BioWatch: Amarin Joins Ten-Bagger Chase (AMRN)

Buying A $100,000 Kidney: A Story of Supply and Demand

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Dividend Watch: Making Income From Healthcare Facility REITs (OHI, MPW)

BioWatch: Curis Gets Further on Cancer Map (CRIS)

BioWatch: Cubist Moves Beyond Patent Fears (CBST, TEVA)

BioWatch: VIVUS & Orexigen Looking More FDA-Favorable (VVUS, OREX, ARNA)

BioWatch: Dendreon Looks Even Brighter (DNDN)

DrugWatch: K-V Tries a Do-Over Approach on Makena (KV-A)

BioWatch: Biotechs With 50% Implied Upside (GENZ, CEPH, ALNY, DNDN, GERN, HALO, VVUS)

IPO Watch: The Alternative Genzyme IPO (SNY, GENZ, GCVRZ, BBH, IBB, FBT)

BioWatch: CryoLife Acquisition, It Is Not Crying (CRY, CGCP)

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Featured Reads

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500